American Health & Drug Benefits

Recent Articles

Clinical, Original Research

College Students’ Perceptions About Prescription Drug Misuse Among Peers

Chibuzo Iloabuchi, BPharm, Eiman Aboaziza, MD, Xiaohui Zhao, MS, PhD, J. Douglas Thornton, PharmD, PhD, Nilanjana Dwibedi, BPharm, MBA, PhD

Business, Original Research

Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer

Neil T. Mason, MBA, Jason M. Burkett, CPA, MACC, Ryan S. Nelson, PharmD, Julio M. Pow-Sang, MD, Robert A. Gatenby, MD, Timothy Kubal, MD, MBA, John W. Peabody, MD, PhD, G. Douglas Letson, MD, Howard L. McLeod, PharmD, Jingsong Zhang, MD, PhD

Clinical, Review Article

Negative Consequences of the Widespread and Inappropriate Easy Access to Purchasing Prescription Medications on the Internet

Jack E. Fincham, PhD, RPh

The Dirty Dozen Redux

David B. Nash, MD, MBA

Pandemic Posting

David B. Nash, MD, MBA

UnHealthcare

David B. Nash, MD, MBA

Most Popular Articles

Clinical, Original Research

College Students’ Perceptions About Prescription Drug Misuse Among Peers

Chibuzo Iloabuchi, BPharm, Eiman Aboaziza, MD, Xiaohui Zhao, MS, PhD, J. Douglas Thornton, PharmD, PhD, Nilanjana Dwibedi, BPharm, MBA, PhD

FDA Approvals

Tecartus First CAR T-Cell Therapy FDA Approved for Patients with Mantle-Cell Lymphoma

FDA Approvals, Lung Cancer

Zepzelca New Therapy Approved for Metastatic Small-Cell Lung Cancer

Business, Original Research

Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer

Clinical, Review Article

Negative Consequences of the Widespread and Inappropriate Easy Access to Purchasing Prescription Medications on the Internet

Jack E. Fincham, PhD, RPh

Business, Original Research

Knee Osteoarthritis Treatment Costs in the Medicare Patient Population

Gerard Malanga, MD, Faizan Niazi, PharmD, Vasco Deon Kidd, DHSc, MPH, MS, PA-C, Edmund Lau, MS, Steven M. Kurtz, PhD, Kevin L. Ong, PhD, PE, Andrew L. Concoff, MD, FACR, CAQSM

Web Exclusives

AVBCC 2020 Highlights

Expert Insights on Innovation in the Oncology Pipeline

ESMO 2020 Highlights

Sotorasib, First-in-Class KRAS G12C Inhibitor, Hailed as “Triumph of Drug Discovery”

Phoebe Starr

FDA Approvals

Keytruda plus Chemotherapy Approved for Unresectable or Metastatic Triple‑Negative Breast Cancer